Good Morning, Y'all! It's officially Scotland Week - whoo hoo! Carlie and I are going to be coming to you loud and proud from the UK so get ready for all kinds of insanity. But before we do that, I want to share the "side gig" Kenneth and I have been working on since April. … Continue reading 12.3.18 Monat Gratitude Week
Reading
I love to read and enjoy sharing my takeaways
5 Things That Keep Me Motivated
ALS or otherwise, I think all of us could benefit from this list. via 5 Things That Keep Me Motivated by Dagmar Munn
11.30.18 November is National Family Caregivers Month
This awesome video was put together by the ALS Association from our interviews at Advocacy Conference in honor of National Family Caregivers Month. I'll be the first and loudest to tell you that my primary caregiver, aka my husband, is the cutest and bestest in the history of ever. Caregiving, whether family or paid service, … Continue reading 11.30.18 November is National Family Caregivers Month
Living Loudly and Laughing with Dysarthria
I can hear the ALS in my voice, but I appreciate everyone's lies that "it's not that bad". via Living Loudly and Laughing with Dysarthria by Dagmar Munn
The End of the Journey
via The End of the Journey via Celebrate the life of Kathryn M Manginelli
David Hasslehoff, more celebs mourn ‘SpongeBob SquarePants’ creator Stephen Hillenburg
David Hasslehoff, more celebs mourn 'SpongeBob SquarePants' creator Stephen Hillenburg "Sponge Bob" was Nickelodeon's all-time biggest hit. Creator Stephen Hillenburg died Monday at age 57 from ALS, a disease he revealed in 2017. Check out this story on USATODAY.com: https://www.usatoday.com/story/life/tv/2018/11/27/spongebob-squarepants-creator-stephen-hillenburg-dies-57-als/2126368002/https://www.usatoday.com/story/life/tv/2018/11/27/spongebob-squarepants-creator-stephen-hillenburg-dies-57-als/2126368002/
ALS Organizations Collaborate to Advance New Therapeutic into Trials
Contact: Brian Frederick The ALS Association (202) 464-8612 bfrederick@alsa-national.org FOR IMMEDIATE RELEASE ALS Organizations Collaborate to Advance New Therapeutic into Trials First dose of potential treatment AT-1501 given to humans by Anelixis Therapeutics to determine safety and tolerability Boston, MA (November 28, 2018) — Several ALS organizations announced on Wednesday that the first participant was successfully … Continue reading ALS Organizations Collaborate to Advance New Therapeutic into Trials
AMG Among Founding Donors to Establish The Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital
PRESS RELEASE AMG Among Founding Donors to Establish The Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital Published: Nov 28, 2018 8:31 a.m. ET WEST PALM BEACH, Fla., Nov 28, 2018 (GLOBE NEWSWIRE via COMTEX) -- WEST PALM BEACH, Fla., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Affiliated Managers Group, Inc. AMG, +2.97% a global … Continue reading AMG Among Founding Donors to Establish The Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital
Participants Now Enrolling in Phase 1 Study on AT-1501, a Potential Treatment for ALS
Participants Now Enrolling in Phase 1 Study on AT-1501, a Potential Treatment for ALS Published Wednesday, November 28, 2018 Author Emer Martin CAMBRIDGE, MA | November 28, 2018 – The ALS Therapy Development Institute (ALS TDI) is proud to announce that the first participant was successfully given a dose of AT-1501 in the first clinical trial of the experimental treatment … Continue reading Participants Now Enrolling in Phase 1 Study on AT-1501, a Potential Treatment for ALS
Meet the 2018 Patient Fellows
Carlie and I can’t wait to check another country off our list! Get ready, we’re bringing Texas to Scotland and ALS Awareness to a whole other level! via Meet the 2018 Patient Fellows
SunnyStrong 